| 英文名称 | 中文名称 | CAS | MF |
|
tert-butyl 4,4-difluoro-1-oxa-6-azaspiro[2.5]octane-6-carboxylate
|
4,4-二氟-1-氧杂-6-氮杂螺[2.5]辛烷-6-羧酸叔丁酯
|
2137836-39-4
|
C11H17F2NO3
|
|
Hydrazine, (2,3,6-trifluorophenyl)-, hydrochloride (1:1)
|
(2,3,6-三氟苯基)肼盐酸盐
|
2137836-61-2
|
C6H6ClF3N2
|
|
7-Bromo-3-nitro-1H-indole
|
|
2137837-43-3
|
C8H5BrN2O2
|
|
1-(2-CHLORO-4-FLUOROPHENYL)ETHANAMINE HCl
|
1-(2-CHLORO-4-FLUOROPHENYL)ETHANAMINE HCl
|
2137857-41-9
|
C8H10Cl2FN
|
|
octahydrocyclopenta[b]pyrrole hydrochloride
|
OCTAHYDROCYCLOPENTA[B]PYRROLE HYDROCHLORIDE
|
2137857-51-1
|
C7H14ClN
|
|
rac-(4aR,7aR)-octahydro-1lambda6-thiopyrano[2,3-c]pyrrole-1,1-dione hydrochloride, cis
|
RAC-(4AR,7AR)-OCTAHYDRO-1LAMBDA6-THIOPYRANO[2,3-C]PYRROLE-1,1-DIONE HYDROCHLORIDE, CIS
|
2137857-68-0
|
C7H14ClNO2S
|
|
2-Amino-N-(4-aminophenyl)acetamid e dihydrochloride
|
2-Amino-N-(4-aminophenyl)acetamid e dihydrochloride
|
2137859-12-0
|
C8H12ClN3O
|
|
6-Bromo-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline
|
6-溴-7-(三氟甲基)-1,2,3,4-四氢喹啉
|
2137894-01-8
|
C10H9BrF3N
|
|
Carbamic acid, N-[4-amino-5-[[4-[(21-chloro-5,8-dioxo-12,15-dioxa-4,9-diazaheneicos-1-yl)oxy]-3,5-dimethoxyphenyl]methyl]-2-pyrimidinyl]-, [7-(diethylamino)-2-oxo-2H-1-benzopyran-4-yl]methyl ester
|
化合物 Coumarin-TMP-Halo
|
2137894-99-4
|
C45H62ClN7O11
|
|
3-Benzofurancarboxylic acid, 7-bromo-2,3-dihydro-, methyl ester
|
3-Benzofurancarboxylic acid, 7-bromo-2,3-dihydro-, methyl ester
|
2137895-68-0
|
C10H9BrO3
|
|
2-(4-chlorophenyl)-4-(dibenzo[b,d]furan-4-yl)-6-phenyl-1,3,5-triazine
|
|
2137919-52-7
|
C27H16ClN3O
|
|
2-(3-chlorophenyl)-4-(dibenzo[b,d]furan-4-yl)-6-phenyl-1,3,5-triazine
|
|
2137919-54-9
|
C27H16ClN3O
|
|
1,3,5-Triazine, 2-(3-chlorophenyl)-4-(1-dibenzofuranyl)-6-phenyl-
|
2-(3-氯苯基)-4-(1-二苯并呋喃基)-6-苯基-1,3,5-三嗪
|
2137919-55-0
|
C27H16ClN3O
|
|
diethyl 2-methyl-2-(6-oxo-1H-pyridin-3-yl)propanedioate
|
2-(6-羟基吡啶-3-基)-2-甲基丙二酸二乙酯
|
2137933-75-4
|
C13H17NO5
|
|
Dibenzothiophene, 3,7-bis(methylthio)-, 5,5-dioxide
|
3,7-双(甲硫基)-5,5-二氧化物二苯并噻吩
|
2137955-61-2
|
C14H12O2S3
|
|
2137975-08-5
|
2137975-08-5
|
2137975-08-5
|
C20H26N6O3
|
|
4-Chloro-3-methoxy-5-nitrobenzamide
|
4-Chloro-3-methoxy-5-nitrobenzamide
|
2137975-62-1
|
C8H7ClN2O4
|
|
Benzamide, 4-chloro-3-hydroxy-5-nitro-
|
4-氯-3-羟基-5-硝基苯甲酰胺
|
2137975-63-2
|
C7H5ClN2O4
|
|
2-(aminomethyl)pyridin-4-amine dihydrochloride
|
2-(aminomethyl)pyridin-4-amine dihydrochloride
|
2137987-01-8
|
C6H10ClN3
|
|
tert-butyl 5,5-difluoro-2,7-diazaspiro[3.4]octane-2-carboxylate
|
tert-butyl 5,5-difluoro-2,7-diazaspiro[3.4]octane-2-carboxylate
|
2137997-74-9
|
C11H18F2N2O2
|
|
7-Fluoro-1H-pyrazolo[3,4-c]pyridine
|
7-氟-1H-吡唑并[3,4-C]吡啶
|
2138028-44-9
|
C6H4FN3
|
|
(4-methyl-2-oxabicyclo[2.1.1]hexan-1-yl)methanamine
|
(4-methyl-2-oxabicyclo[2.1.1]hexan-1-yl)methanamine
|
2138031-00-0
|
C7H13NO
|
|
methyl 2-amino-2-(3-bromophenyl)propanoate hydrochloride
|
甲基 2-氨基-2-(3-溴苯基)丙酯盐酸
|
2138131-80-1
|
C10H13BrClNO2
|
|
(S)-N-methyl(pyrrolidin-2-yl)methanamine dihydrochloride
|
(S)-N-methyl(pyrrolidin-2-yl)methanamine dihydrochloride
|
2138133-16-9
|
C6H15ClN2
|
|
2-(bromomethyl)-4-chloropyridine hydrobromide
|
2-(溴甲基)-4-氯吡啶氢溴酸盐
|
2138157-53-4
|
|
|
2-Oxabicyclo[2.1.1]hexane-4-methanol, 1-methyl-
|
2-Oxabicyclo[2.1.1]hexane-4-methanol, 1-methyl-
|
2138162-49-7
|
C7H12O2
|
|
CYCLOPROPYL[3-(TRIFLUOROMETHYL)PHENYL]METHANAMINE HYDROCHLORIDE
|
CYCLOPROPYL[3-(TRIFLUOROMETHYL)PHENYL]METHANAMINE HYDROCHLORIDE
|
2138165-87-2
|
C11H13ClF3N
|
|
1-(3-FLUORO-4-METHYLPHENYL)ETHAN-1-AMINE HYDROCHLORIDE
|
1-(3-FLUORO-4-METHYLPHENYL)ETHAN-1-AMINE HYDROCHLORIDE
|
2138165-91-8
|
C9H13ClFN
|
|
Brexpiprazole Impurity
|
依匹哌唑杂质
|
2138169-93-2
|
C41H47N5O2S2
|
|
tert-butyl 4-formyl-4-(trifluoromethyl)piperidine-1-carboxylate
|
4-甲酰基-4-(三氟甲基)哌啶-1-羧酸叔丁酯
|
2138192-03-5
|
C12H18F3NO3
|
|
6-Fluoro-2-formyl-3-hydroxybenzoic Acid
|
6-Fluoro-2-formyl-3-hydroxybenzoic Acid
|
2138193-88-9
|
C8H5FO4
|
|
4-bromo-5-iodo-1-methyl-1H-pyrazole
|
4-溴-5-碘-1-甲基-1H-吡唑
|
2138196-27-5
|
C4H4BrIN2
|
|
2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid
|
2-(((9H-芴-9-基)甲氧基)羰基)-1,2,3,4-四氢异喹啉-6-羧酸
|
2138226-21-6
|
C25H21NO4
|
|
2-(4,4-DIFLUOROOXAN-3-YL)ETHAN-1-OL
|
|
2138229-45-3
|
C7H12F2O2
|
|
1-(2-bromoethyl)-4,4-difluoropiperidine hydrobromide
|
1-(2-溴乙基)-4,4-二氟哌啶氢溴酸盐
|
2138280-09-6
|
C7H13Br2F2N
|
|
MIL-124(In)
|
/
|
2138292-58-5
|
C9H4In2O10
|
|
STING agonist-3
|
STING AGONIST-3
|
2138299-29-1
|
C37H42N12O6
|
|
1H-Benzimidazole-5-carboxamide, 1-[(2E)-4-[5-(aminocarbonyl)-2-[[(1-ethyl-3-methyl-1H-pyrazol-5-yl)carbonyl]amino]-7-methoxy-1H-benzimidazol-1-yl]-2-buten-1-yl]-2-[[(1-ethyl-3-methyl-1H-pyrazol-5-yl)carbonyl]amino]-7-[3-(4-morpholinyl)propoxy]-
|
DIABZI STING AGONIST-1
|
2138299-33-7
|
C42H51N13O7
|
|
diABZI STING agonist-1 trihydrochloride
|
DIABZI STING AGONIST-1 TRIHYDROCHLORIDE
|
2138299-34-8
|
C42H52ClN13O7
|
|
1H-Benzimidazole-5-carboxamide, 1,1'-(1,4-butanediyl)bis[2-[[(1-ethyl-3-methyl-1H-pyrazol-5-yl)carbonyl]amino]-
|
STING AGONIST-4
|
2138300-40-8
|
C34H38N12O4
|
|
4-Chloro-3-(3-methoxypropoxy)-5-nitrobenzamide
|
3-(3-甲氧基丙氧基)-4-氯-5-硝基苯甲酰胺
|
2138302-17-5
|
C11H13ClN2O5
|
|
2-Pyrimidinemethanamine, α-methyl-, hydrochloride (1:2)
|
1-(嘧啶-2-基)乙胺二盐酸
|
2138337-19-4
|
C6H10ClN3
|
|
Pyrazolo[1,5-a]pyridine, 3-chloro-4,5,6,7-tetrahydro-
|
3-氯-4,5,6,7-四氢吡唑并[1,5-A]吡啶
|
2138386-72-6
|
C7H9ClN2
|
|
rac-(2R,3S)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-2-(3-methoxyphenyl)pyrrolidine-3-carboxylic acid, cis
|
RAC-(2R,3S)-1-{[(9H-FLUOREN-9-YL)METHOXY]CARBONYL}-2-(3-METHOXYPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID
|
2138388-57-3
|
C27H25NO5
|
|
1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-
|
利格列汀杂质26
|
2138392-83-1
|
C26H21BrN8O2
|
|
Ethanone, 1-[3-chloro-4-fluoro-5-(trifluoromethyl)phenyl]-2,2,2-trifluoro-
|
1-(3-CHLORO-4-FLUORO-5-(TRIFLUOROMETHYL)PHENYL)-2,2,2-TRI
|
2138407-75-5
|
C9H2ClF7O
|
|
1-Azetidinecarboxylic acid, 3-(cyanomethyl)-3-[4-[7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]-, 1,1-dimethylethyl ester
|
|
2138410-61-2
|
C25H25N7O4S
|
|
2-(pyrrolidin-3-yl)pyridine dihydrochloride
|
2-(pyrrolidin-3-yl)pyridine dihydrochloride
|
2138411-43-3
|
C9H13ClN2
|
|
4-((2-(2-aminoethoxy)ethyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
|
4-((2-(2-氨基乙氧基)乙基)氨基)-2-(2,6-二氧代-哌啶-3-基)异吲哚-1,3-二酮
|
2138439-12-8
|
C17H20N4O5
|
|
(S,R,S)-AHPC-C4-NH2
|
(S,R,S)-AHPC-C4-NH2
|
2138439-53-7
|
C27H39N5O4S
|
|
2-(2,6-dioxopiperidin-3-yl)-4-((2-(prop-2-yn-1-yloxy)ethyl)amino)isoindoline-1,3-dione
|
2-(2,6-二氧代哌啶-3-基)-4-((2-(丙-2-炔-1-基氧基)乙基)氨基)异吲哚啉-1,3-二酮
|
2138439-55-9
|
C18H17N3O5
|
|
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-(2-propyn-1-yloxy)ethoxy]ethyl]amino]-
|
泊马度胺-二聚乙二醇-炔基
|
2138439-56-0
|
C20H21N3O6
|
|
2-(2,6-dioxopiperidin-3-yl)-4-((2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)amino)isoindoline-1,3-dione
|
2-(2,6-二氧代哌啶-3-基)-4-((2-(2-(2-(丙-2-炔-1-基氧基)乙氧基)乙氧基)乙基)氨基)异吲哚啉-1,3-二酮
|
2138439-57-1
|
C22H25N3O7
|
|
Pomalidomide-PEG4-CO2H
|
POMALIDOMIDE-PEG4-CO 2 H
|
2138440-81-8
|
C24H31N3O10
|
|
Pomalidomide-PEG3-CO2H
|
Pomalidomide-PEG3-CO2H
|
2138440-82-9
|
C22H27N3O9
|
|
Butanoic acid, 3-hydroxy-, calcium salt (2:1), (3R)-
|
R-3-羟基丁酸钙
|
2138463-93-9
|
C4H10CaO3
|
|
N-Fmoc-N-methyl-3-(2-naphthyl)-L-alanine
|
FMOC-N-METHYL-3-(2-NAPHTHYL)-L-ALANINE
|
2138482-09-2
|
C29H25NO4
|
|
Dibenzofuran, 2-bromo-6-chloro-
|
2-溴-6-氯二苯并呋喃
|
2138490-84-1
|
C12H6BrClO
|
|
TBDI-DFBT
|
TBDI-DFBT
|
2138496-98-5
|
|
|
diABZI STING agonist-1 Tautomerism
|
DIABZI STING AGONIST-1 (TAUTOMERISM)
|
2138498-18-5
|
C42H51N13O7
|
|
CDK4/6-IN-4
|
CDK4/6-IN-4
|
2138499-06-4
|
C27H32F2N8O
|
|
5,6-difluoro-1,2,3,4-tetrahydroisoquinoline hydrochloride
|
5,6-二氟-1,2,3,4-四氢异喹啉盐酸
|
2138522-82-2
|
C9H10ClF2N
|
|
5-(4-cyclopropylphenyl)-1H-pyrrole-2-carboxylicacid
|
5-(4-cyclopropylphenyl)-1H-pyrrole-2-carboxylicacid
|
2138546-95-7
|
C14H13NO2
|
|
Raltegravir EP impurity F
|
Raltegravir EP impurity F
|
2138805-56-6
|
C22H27FN6O6
|
|
Amlodipine Impurity D
|
氨氯地平杂质D
|
2138811-33-1
|
C24H27ClN2O9
|
|
GSK3004774
|
GSK3004774
|
2138814-32-9
|
C32H40N4O3
|
|
ABBV-744
|
ABBV-744
|
2138861-99-9
|
C28H30FN3O4
|
|
Ethanone, 1-[3-bromo-4-(4-fluoro-2,6-dimethylphenoxy)phenyl]-
|
1-[3-溴-4-(4-氟-2,6-二甲基-苯氧基)苯基]乙酮
|
2138863-82-6
|
C16H14BrFO2
|
|
Tetrakis(4-quinolinylphenyl)ethylene
|
四(4-喹啉基苯基)乙烯
|
2138865-23-1
|
C62H40N4
|
|
KEA1-97
|
KEA1-97
|
2138882-71-8
|
C15H9Cl2FN4
|
|
Naloxone Impurity 3(Naloxone EP Impurity C)
|
纳洛酮杂质3
|
2139253-68-0
|
C19H21NO5
|
|
Naloxone EP Impurity F
|
纳洛酮EP杂质F
|
2139253-69-1
|
C19H21NO5
|
|
THAL-SNS-032
|
THAL-SNS-032
|
2139287-33-3
|
C40H52N8O10S2
|
|
1,3-Dihydrofuro[3,4-c]pyridine hydrochloride
|
1,3-Dihydrofuro[3,4-c]pyridine hydrochloride
|
2139294-73-6
|
C7H8ClNO
|
|
Methyl 7-azaspiro[3.5]nonane-2-carboxylate hydrochloride
|
7-氮杂螺并[3.5]壬烷-2-羧酸甲酯盐酸盐
|
2139294-75-8
|
C10H18ClNO2
|
|
2-Methyl-1,2,3,4-tetrahydroisoquinolin-6-amine dihydrochloride
|
2-甲基1,2,3,4-四氢异喹啉-6-胺二盐酸盐
|
2139294-76-9
|
C10H15ClN2
|
|
SERCA2a activator A
|
SERCA2a activator A
|
2139330-34-8
|
C32H29N3O4S
|
|
5H-Pyrrolo[2,3-d]pyrimidine, 2,4-dichloro-6,7-dihydro-
|
2,4-二氯-6,7-二氢-5H-吡咯并[2,3-D]嘧啶
|
2139336-89-1
|
C6H5Cl2N3
|
|
POMALIDOMIDE-PEG1-CO2H
|
POMALIDOMIDE-PEG 1-CO 2 H
|
2139348-60-8
|
C18H19N3O7
|
|
Pomalidomide-PEG5-CO2H
|
泊马度胺-五聚乙二醇-酸
|
2139348-63-1
|
C26H35N3O11
|
|
AMPD2 inhibitor 1
|
AMPD2 inhibitor 1
|
2139356-35-5
|
C25H22N2O2
|
|
Nilotinib 3-Imidazolyl N-oxide
|
Nilotinib 3-Imidazolyl N-oxide
|
2139382-75-3
|
C28H22F3N7O2
|
|
1-(3-(difluoromethyl)-2-fluorophenyl)ethan-1-one
|
1-(3-(二氟甲基)-2-氟苯基)乙酮
|
2139441-40-8
|
C9H7F3O
|
|
(1R,2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)cyclobutanecarboxylic acid
|
(1R,2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)cyclobutanecarboxylic acid
|
2140262-82-2
|
C20H19NO4
|
|
Linagliptin iMpurity
|
利拉利汀杂质
|
2140263-92-7
|
C25H28N8O2
|
|
ClindaMycin-13C-d3
|
克林霉素-13C-D3
|
2140264-63-5
|
C18H30ClD3N2O5S
|
|
Dicloxacillin 13C4
|
Dicloxacillin 13C4
|
2140264-78-2
|
C19H17Cl2N3O5S
|
|
1-tert-Butyl 3-methyl (3S,4R)-4-phenylpyrrolidine-1,3-dicarboxylate
|
1-tert-Butyl 3-methyl (3S,4R)-4-phenylpyrrolidine-1,3-dicarboxylate
|
2140264-81-7
|
C17H23NO4
|
|
methyl (3r,4r)-4-(trifluoromethyl)pyrrolidine-3-carboxylate hcl
|
methyl (3r,4r)-4-(trifluoromethyl)pyrrolidine-3-carboxylate hcl
|
2140264-93-1
|
C7H11ClF3NO2
|
|
(3S,4R)-3-fluoro-4-methoxypiperidine
|
(3S,4R)-3-氟-4-甲氧基哌啶
|
2140267-29-2
|
C6H12FNO
|
|
(3S,4R)-3-fluoro-4-methoxypiperidine hydrochloride
|
(3S,4R)-3-氟-4-甲氧基哌啶盐酸盐
|
2140267-30-5
|
C6H13ClFNO
|
|
BETd-246
|
BETD-246
|
2140289-17-2
|
C48H55N11O10
|
|
PF-06700841-TsOH
|
CS-2860
|
2140301-96-6
|
C25H29F2N7O4S
|
|
1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one malonate
|
化合物 T5382L
|
2140301-97-7
|
C18H23N5O5
|
|
PF-04634817 succinate
|
PF-04634817 succinate
|
2140301-98-8
|
C29H42F3N5O7
|
|
Methyl 4-bromo-3-carbamoylbenzoate
|
4-溴-3-氨基甲酰基苯甲酸甲酯
|
2140305-53-7
|
C9H8BrNO3
|
|
7-Bromo-4-methoxyquinazoline
|
7-溴-4-甲氧基喹唑啉
|
2140305-93-5
|
C9H7BrN2O
|
|
Prucalopride-13CD3
|
普芦卡必利杂质
|
2140306-00-7
|
C18H23ClD3N3O3
|
|
2,8-Diazaspiro[4.5]decane, 2-methyl-, hydrochloride (1:2)
|
2-甲基-2,8-二氮杂螺[4.5]癸烷二盐酸盐
|
2140316-58-9
|
C9H19ClN2
|
|
Vortioxetine D8
|
Vortioxetine D8
|
2140316-62-5
|
C18H22N2S
|